OSELLA ABATE, Simona
 Distribuzione geografica
Continente #
NA - Nord America 6.400
EU - Europa 4.135
AS - Asia 2.060
SA - Sud America 124
OC - Oceania 62
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.832
Nazione #
US - Stati Uniti d'America 6.303
IT - Italia 1.110
CN - Cina 861
IE - Irlanda 483
SG - Singapore 424
FR - Francia 360
DE - Germania 354
KR - Corea 329
SE - Svezia 311
FI - Finlandia 257
AT - Austria 243
DK - Danimarca 180
GB - Regno Unito 167
UA - Ucraina 159
PL - Polonia 126
ES - Italia 123
IN - India 98
JP - Giappone 88
VN - Vietnam 88
CA - Canada 74
AU - Australia 57
BR - Brasile 50
NL - Olanda 50
ID - Indonesia 46
TR - Turchia 34
BE - Belgio 30
RU - Federazione Russa 25
AR - Argentina 23
SN - Senegal 22
GR - Grecia 21
HK - Hong Kong 21
CO - Colombia 19
RO - Romania 19
CH - Svizzera 18
TW - Taiwan 17
CL - Cile 16
HU - Ungheria 16
MX - Messico 16
RS - Serbia 16
PT - Portogallo 10
CZ - Repubblica Ceca 9
NO - Norvegia 9
AE - Emirati Arabi Uniti 7
EG - Egitto 7
EU - Europa 7
LV - Lettonia 7
IL - Israele 6
SI - Slovenia 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
HR - Croazia 5
IR - Iran 5
NZ - Nuova Zelanda 5
PE - Perù 5
ZA - Sudafrica 5
CR - Costa Rica 4
EC - Ecuador 4
MY - Malesia 4
NG - Nigeria 4
PH - Filippine 4
PK - Pakistan 4
AL - Albania 3
BG - Bulgaria 3
LB - Libano 3
QA - Qatar 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
LT - Lituania 2
MK - Macedonia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GT - Guatemala 1
IQ - Iraq 1
JO - Giordania 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
PA - Panama 1
SM - San Marino 1
TG - Togo 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 12.832
Città #
Chandler 725
Beijing 512
Dublin 479
Santa Clara 401
Houston 399
Torino 364
Singapore 348
Fairfield 307
Ashburn 270
Vienna 238
Villeurbanne 238
Ann Arbor 226
Wilmington 191
Woodbridge 181
Medford 180
Princeton 179
Jacksonville 175
Dearborn 162
Nyköping 139
Columbus 130
Redwood City 122
Seattle 120
Warsaw 104
Cambridge 103
Pisa 100
Milan 66
Dong Ket 52
Pune 52
Turin 52
New York 51
Jakarta 40
Boston 36
Guangzhou 36
Helsinki 34
Fremont 32
Boardman 31
Washington 31
Nanjing 28
Norwalk 28
Toronto 26
Hefei 25
Shanghai 24
Tokyo 24
Brussels 23
San Diego 21
Munich 18
Rome 17
Bologna 16
Kunming 16
Madrid 16
Ottawa 16
Silver Spring 16
Chengdu 15
Los Angeles 15
Seoul 14
Barcelona 13
London 13
Mountain View 13
Philadelphia 13
Sydney 13
Upper Marlboro 13
Rochester 12
Taipei 11
Central 10
Jinan 10
Lachine 10
Leiden 10
Melbourne 10
Nürnberg 10
Phoenix 10
Amsterdam 9
Falls Church 9
Hangzhou 9
Hebei 9
Naples 9
Shenyang 9
Athens 8
Belgrade 8
Denver 8
Fuzhou 8
Istanbul 8
Nanchang 8
Newcastle Upon Tyne 8
Paris 8
Pavia 8
Santiago 8
São Paulo 8
Berlin 7
Bogotá 7
Chicago 7
Córdoba 7
New Haven 7
Nuremberg 7
Serra 7
Verona 7
Bucharest 6
Central District 6
Changsha 6
Chiba 6
Falkenstein 6
Totale 7.663
Nome #
Prognostic role of Histologic regression in primary cutaneous melanoma: A Systematic Review and Meta-analysis 508
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up. 466
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre. 377
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study 307
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome 255
Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years. 254
Novel CALR somatic mutations in essential thrombocythaemia 245
Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review 239
Giornale italiano di Dermatologia e Venereologia 233
Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients. 231
Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group 219
Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role? 216
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up 215
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of Β-cyclodextrin enhances the antitumoralefficacyof the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model 211
FOXA1 and AR in invasive breast cancer: New findings on their co-expression and impact on prognosis in ER-positive patients 181
Expression of AP-2a, AP-2g and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value 178
Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma 178
Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes. 171
Eruptive Dermal Clear Cell Desmoplastic Mesenchymal Tumors with Myofibroblastic Differentiation in a Young Boy. 156
Prediction of high naevus count in a healthy U.K. population to estimate melanoma risk 150
Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma. 147
Prognostic differences across sexes in melanoma patients: What has changed from the past? 134
Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene 133
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis 131
Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling 129
Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: A single centre observational cohort study. 123
microRNA-214 promotes melanoma tumor progression 122
Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients. 117
Melanoma immunotherapy. 116
TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk 115
Studio citofluorimetrico della popolazione circolante CD4+CD27+ nelle eritrodermie infiammatorie e nei linfomi cutanei: relazione con i livelli di cellule CD4+CD26- ed utilità diagnostica. 112
Phenotypic characterisation of immune cells associated with histological regression in cutaneous melanoma 111
Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern 110
The role of the AR/ER ratio in ER-positive breast cancer patients 109
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 109
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 107
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas 106
The risk of melanoma in airline pilots and cabin crew: A meta-analysis 103
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 101
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients. 100
VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course. 100
Prognostic characterization of higher-grade meningiomas: A histopathological score to predict progression and outcome 100
Metastatic colorectal cancer prior to expanded RAS assessment: Evidence from long-term outcome analysis of a real-life cohort within a dedicated colorectal cancer unit 97
Endothelial and Smooth muscle cell Derived Neuropin-like molecule and AP-2 family protein expression in primary melanoma predicts Disease Free Survival in melanoma patients 94
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 93
BRAFi/MEKi in patients with metastatic melanoma: Predictive factors of complete response 93
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: A multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium 92
Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients. 91
Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status 90
Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphea. 87
1975-2011 Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed? 87
Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study 85
Pathological prognostic markers in central nervous system solitary fibrous tumour/ hemangiopericytoma: Evidence from a small series 85
Improvement of sensitivity in sentinel lymph node procedure in melanoma patients. 84
Eritema polimorfo, Sindrome di Stevens-Johnson, Necrolisi epidermica tossica: istologia 84
The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells 83
Electrochemotherapy in treatment of skin melanoma metastases 83
Bullous pemphigoid is characterised by a reduction of skin-homing/circulating FOXP3+ Tregs and by a down-regulation of the IL-10 pathway 81
CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients. 79
Time course and pattern of first relapse in stage I-II primary cutaneous melanoma: a multivariate analysis of disease-free survival in 3,174 patients followed-up at the Turin Melanoma Centre from 1975 to 2004 76
Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients 76
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma 75
Clinical significance of sequential tyrosinase expression in the peripheral blood of disease-free melanoma patients: a review of literature data 74
Caratterizzazione immunoistochimica e citofluorimetrica di una nuova linea di melanoma. 74
What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients? 73
Atypical mononuclear cells in “Neutrophilic Dermatitis” 73
Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study 73
Progressione di malattia nei pazienti affetti da melanoma con linfonodo sentinella negativo 72
FOXP3 AND MELANOMA: THE BIG ESCAPE? 71
Clinic-pathologic features of sentinel lymph nodes predictive for non-sentinel lymph node involvement, disease-free survival and overall survival in melanoma patients 70
FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy. 69
Butyric acid effects on melanoma cell lines: apoptosis induction and cell cycle cytofluorimetric evaluation 69
Skin metastases of malignant melanoma: a clinical and prognostic survey 66
Prognostic role of histological regression in cutaneous melanoma 66
Utilità dell’RT-PCR per la tirosinasi nel monitoraggio dei pazienti affetti da melanoma in stadio III. 65
False negative rate in patients with cutaneous melanoma submitted to sentinel lymph node biopsy 65
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome 65
Serum interleukin-13 levels are increased in patients with Stevens-Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme 64
Melanoma in patients younger than 20 years. 64
Index risk on sentinel lymph nodes features that could predict non-sentinel lymph node involvement, disease-free survival and overall survival in melanoma patients. 63
miR214 expression and interconnected endothelial and smooth muscle cell derived neutropilin-like molecule ESDN and AP-2 family protein expression in primary melanoma 62
Correlation between DNA-ploidy/cell cycle kynetics and histopathology in primary cutaneous B cell lymphomas 62
Prognostic Analysis of the IDH1 G105G (rs11554137) SNP in IDH-Wildtype Glioblastoma 62
Immature myeloid precursors in chronic neutrophilic dermatosis associated with myelodysplastic syndrome. 61
Squamocellular Carcinoma of the Skin: Clinicopathological Features Predicting the Involvement of the Surgical Margins and Review of the Literature 61
Caveolin-1 in Kidney Chronic Antibody-Mediated Rejection: An Integrated Immunohistochemical and Transcriptomic Analysis Based on the Banff Human Organ Transplant (B-HOT) Gene Panel 61
Clinical significance of tyrosinase expression in the peripheral blood of stage III disease-free melanoma patient 59
Significato prognostico dei livelli sierici di interleuchina-12 endogena in pazienti affetti da melanoma metastatico in fase avanzata trattati con chemioterapia o chemioimmunoterapia. 59
Tyrosinase mRNA RT-PCR analysis as an additional diagnostic tool for the identification of melanoma cells in biological fluid samples other than blood: a preliminary report 59
From the Aosta valley to the Sicily it is Always melanoma but... Results of a multicentric Italian study from the GIPMe 58
Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness 58
Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases 57
Valutazione dei marcatori dell’apoptosi durante terapia con fotoferesi. 57
RT-PCR tyrosinase in the follow-up of melanoma patients 55
Disease progression in melanoma patients with negative sentinel lymph node: does false-negative specimens entirely account for this phenomenon? 55
Role of RT-PCR tyrosinase detection in the monitoring of patients with advanced metastatic melanoma. 54
Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients. 53
Utilità diagnostica della RT-PCR per la tirosinasi nei fluidi biologici in pazienti affetti da melanoma metastatico 53
Effects of cholesteryl butyrate in solid lipid nanospheres on melanoma cell lines: apoptosis induction and cell cycle flow-cytometric evaluation 52
Sequential peripheral blood tyrosinase expression is an independent time-related prognostic parameter in Stage III and IV metastatic melanoma patients: A clinical follow-up study of 310 patients at a single institution. 52
Totale 11.626
Categoria #
all - tutte 39.028
article - articoli 0
book - libri 0
conference - conferenze 8.547
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.575


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.037 0 0 0 0 0 0 228 162 179 173 135 160
2020/20211.188 164 77 102 80 92 91 77 65 77 122 94 147
2021/20221.458 60 55 78 117 88 67 83 78 43 86 327 376
2022/20232.181 282 150 50 178 190 548 177 141 226 48 127 64
2023/20241.010 129 150 76 66 73 170 22 46 6 47 75 150
2024/20251.366 32 154 103 237 686 145 9 0 0 0 0 0
Totale 13.339